Heparanase: A Challenging Cancer Drug Target.
Ontology highlight
ABSTRACT: Heparanase has been viewed as a promising anti-cancer drug target for almost two decades, but no anti-heparanase therapy has yet reached the clinic. This endoglycosidase is highly expressed in a variety of malignancies, and its high expression is associated with greater tumor size, more metastases, and a poor prognosis. It was first described as an enzyme cleaving heparan sulfate chains of proteoglycans located in extracellular matrices and on cell surfaces, but this is not its only function. It is a multi-functional protein with activities that are enzymatic and non-enzymatic and which take place both outside of the cell and intracellularly. Knowledge of the crystal structure of heparanase has assisted the interpretation of earlier structure-function studies as well as in the design of po
SUBMITTER: Coombe DR
PROVIDER: S-EPMC6892829 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
ACCESS DATA